ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000228544.1	Gefitinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.034229629	Resistant
ENSG00000228544.1	Gefitinib	Sarcoma	0.032325193	Sensitive